West Pharmaceutical Services Inc (WST) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
Over the past 4 years, West Pharmaceutical Services Inc has achieved a revenue compound annual growth rate (CAGR) of 7.7%, while earnings have grown at 49.6% CAGR.
Historical revenue and profitability trends for West Pharmaceutical Services Inc
The chart above illustrates West Pharmaceutical Services Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of West Pharmaceutical Services Inc's business.
How efficiently West Pharmaceutical Services Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue West Pharmaceutical Services Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project West Pharmaceutical Services Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.6923 based on 13 analysts.
Based on our comprehensive analysis, West Pharmaceutical Services Inc (WST) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of West Pharmaceutical Services Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how West Pharmaceutical Services Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: WST Valuation, WST Dividend, WST Financial Health
Compare: WST vs AAPL, WST vs MSFT, WST vs GOOGL